EVOTEC/ DE0005664809 /
| 2024-07-26 4:49:43 PM | Chg. +0.020 | Volume | Bid5:35:25 PM | Ask5:40:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 8.710EUR | +0.23% | 1,000 Turnover: 8,700 |
-Bid Size: - | -Ask Size: - | 1.54 bill.EUR | - | - |
GlobeNewswire
06-04
QUANTRO Therapeutics reaches a milestone in the collaboration with Boehringer Ingelheim to develop f...
GlobeNewswire
06-03
FibroGen Announces FDA Clearance of Investigational New Drug Application for FG-3165, a Galectin-9 T...
GlobeNewswire
06-03
AUROBAC THERAPEUTICS Presents its R&D Strategy & Pipeline and Announces New Development Program in P...
GlobeNewswire
01-16
HOOKIPA Pharma Appoints Mark Winderlich as Chief Development Officer to Lead Clinical Research and ...
GlobeNewswire
2023-12-11
Glycotope and Evotec enter licensing agreement to combine Glycotope antibodies and Evotec’s immune c...
GlobeNewswire
2023-11-30
Zealand Pharma appoints Enrique Conterno and Elaine Sullivan as board observers
GlobeNewswire
2023-11-07
Dewpoint Therapeutics Enters Strategic Partnership with Evotec to Accelerate Oncology Pipeline
GlobeNewswire
2023-10-11
Sernova to Provide Two Program Updates in Podium Presentations at 2023 IPITA Congress
GlobeNewswire
2023-09-29
Sernova Presents Compelling New Data on the Cell Pouch System™ as a Promising Treatment for Post-Ope...
GlobeNewswire
2023-09-14
Sernova Investor Conference Call Previously Scheduled for September 15 Now Rescheduled for September...
GlobeNewswire
2023-09-13
Sernova to Host Investor Calls to Introduce Newly Appointed CEO and Provide Business Update
GlobeNewswire
2022-03-21
Chinook Therapeutics Announces Appointment of Dr. Mahesh Krishnan to its Board of Directors
GlobeNewswire
2022-03-17
Chinook Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financia...
Newsfile Corp
2022-02-17
Awakn Life Sciences Drug Discovery Program Files Patent Application for a New Class of Entactogen-Li...
Newsfile Corp
2022-01-26
Awakn Life Sciences Files Patent Application for a New Class of Entactogen-Like Molecules to Treat a...
GlobeNewswire
2022-01-24
Chinook Therapeutics Announces Appointment of Charlotte Jones-Burton, M.D., M.S. as Senior Vice Pres...
GlobeNewswire
2022-01-10
Updated: Seer Announces Broad Commercial Release of the Proteograph™ Product Suite and Launches Cent...
GlobeNewswire
2022-01-10
Seer Announces Broad Commercial Release of the Proteograph™ Product Suite and Launches Centers of Ex...
GlobeNewswire
2022-01-05
Galecto Adds Experienced Biotech Executive Stephanie Oestreich as Chief Business Officer
GlobeNewswire
2021-12-14
Chinook Therapeutics Receives Orphan Drug Designation from European Commission for Atrasentan for Tr...
GlobeNewswire
2021-11-08
Chinook Therapeutics Provides Business Update and Reports Third Quarter 2021 Financial Results
